Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States

BACKGROUND: Prior to 2018, intravenous bisphosphonates (IV BPs) were the only therapies recommended to prevent skeletal‐related events for patients diagnosed with multiple myeloma (MM). We examined patterns of IV BP initiation and interruption among patients with newly diagnosed MM (NDMM) in the Uni...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Med
Hoofdauteurs: McGrath, Leah J., Hernandez, Rohini K., Overman, Robert, Reams, Diane, Liede, Alexander, Brookhart, M. Alan, O’Donnell, Elizabeth
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2018
Onderwerpen:
Cancer Prevention
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6346250/
https://ncbi.nlm.nih.gov/pubmed/30537194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1869
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items